液體止血劑市場規模、佔有率和成長分析：按類型、應用領域、製劑類型、最終用戶和地區分類－2026-2033年產業預測

2024年全球液體止血劑市場價值為7.8877億美元，預計將從2025年的8.5976億美元成長到2033年的17.1312億美元。預測期（2026-2033年）的複合年成長率預計為9.0%。

全球液體止血劑市場的主要驅動力是術中高效止血管理需求的不斷成長，而這又源於手術數量和複雜性的增加。注射型或塑膠化型局部止血劑，例如明膠和凝血酶基質，可以適用於傳統方法難以處理的不規則傷口。它們的有效性可最大限度地減少輸血需求，縮短手術時間，並降低併發症率。在微創技術發展和監管力度加大的推動下，該市場正從傳統的紗布和粉末轉向專用配方。隨著手術操作日益複雜，對能夠快速止血的液體止血劑的需求不斷成長，醫院也因其臨床和經濟效益而優先採用這些產品，這為新興市場的創新和夥伴關係創造了條件。

全球液體止血劑市場促進因素

外科手術數量的增加和複雜手術的日益普及，推動了臨床對高效止血方案的需求不斷成長。這促使醫療專業人員擴大選擇能夠適應不規則傷口形狀並可快速應用的液體止血劑。外科醫生日益尋求能夠最大限度減少術中出血並改進微創技術的可靠工具，而醫療機構則優先考慮有助於提高手術效率和改善患者預後的產品。這一臨床趨勢，加上其在各個外科專科的廣泛應用，正在增加醫院處方箋中液體止血劑的使用頻率，並推動市場內生成長。

全球液體止血劑市場面臨的限制因素

由於各地監管要求複雜多樣，全球液體止血劑市場面臨許多挑戰。這些法規可能會延遲產品上市，限制市場滲透，尤其對於含有創新生物成分或獨特給藥機制的液體止血劑更是如此。製造商通常需要應對漫長的核准流程，並提供大量的安全性和有效性數據。這不僅使研發工作更加複雜，也佔用了原本用於商業化舉措的資源。此類挑戰可能會阻礙中小企業進入市場，延緩對新產品配方的投資，並最終影響尖端止血解決方案應用於臨床的速度。

全球液體止血劑市場趨勢

受微創手術技術和機器人手術日益普及的推動，全球液體止血劑市場正經歷顯著成長。這一趨勢源於臨床醫生對止血解決方案的需求，這些解決方案能夠有效適應複雜的解剖結構，並在狹小空間內實現快速止血，從而提高手術效率。醫院優先考慮有助於縮短患者住院時間和最佳化手術效率的產品。為此，製造商正積極推進技術創新，以實現產品與手術流程的無縫整合，例如改進包裝、增強與適用器械的兼容性以及提供全面的培訓支持，從而打造明顯的競爭優勢，滿足現代外科醫學不斷變化的需求。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球液體止血劑市場規模：按類型和複合年成長率分類（2026-2033 年）

• 纖維蛋白類止血劑
• 膠原蛋白類止血劑
• 明膠類止血劑

全球液體止血劑市場規模：按應用和複合年成長率分類（2026-2033 年）

• 創傷病例
• 心血管外科
• 整形外科手術
• 其他

全球液體止血劑市場規模：依劑型及複合年成長率分類（2026-2033 年）

• 液體配方
• 粉末製劑

全球液體止血劑市場規模：按最終用戶和複合年成長率分類（2026-2033 年）

• 醫院
• 門診手術中心
• 其他

全球液體止血劑市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Johnson & Johnson
• Medtronic
• B. Braun Melsungen AG
• Ethicon
• Baxter International Inc.
• Cardinal Health
• Z-Medica
• Integra LifeSciences
• MILS Biologics
• CryoLife
• CR Bard
• Sanofi
• Hemostasis, Inc.
• Source BioScience
• Teleflex Incorporated
• Stryker Corporation
• Terumo Corporation
• Abbott Laboratories
• Grifols SA
• Acelity LP Inc.

結論與建議

Global Flowable Hemostats Market size was valued at USD 788.77 Million in 2024 and is poised to grow from USD 859.76 Million in 2025 to USD 1713.12 Million by 2033, growing at a CAGR of 9.0% during the forecast period (2026-2033).

The global flowable hemostats market is primarily driven by the rising demand for efficient intraoperative bleeding control amid increasing surgical procedures and their complexity. These injectable or malleable topical agents, such as gelatin-thrombin matrices, conform to irregular wound beds where traditional methods fail. Their effectiveness minimizes the need for blood transfusions, shortens operating times, and reduces complication rates. This market has transitioned from conventional gauzes and powders to specialized formulations, propelled by the rise of minimally invasive techniques and regulatory emphasis. As surgical complexities grow, the demand for flowable hemostats that ensure rapid hemostasis intensifies, prompting hospitals to prioritize these products for their clinical and economic benefits, thus opening avenues for innovation and partnerships in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Flowable Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Flowable Hemostats Market Segments Analysis

Global flowable hemostats market is segmented by type of hemostat, application area, formulation type, end user and region. Based on type of hemostat, the market is segmented into Fibrin-based Hemostats, Collagen-based Hemostats and Gelatin-based Hemostats. Based on application area, the market is segmented into Trauma Cases, Cardiovascular Surgery, Orthopedic Surgery and Others. Based on formulation type, the market is segmented into Liquid Formulations and Powder Formulations. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Flowable Hemostats Market

The rising number of surgical procedures and more intricate interventions has led to a greater clinical demand for efficient bleeding control solutions, encouraging healthcare professionals to opt for flowable hemostats that adapt to irregular wound shapes and allow for quick application. Surgeons are increasingly seeking dependable tools to minimize intraoperative blood loss and enhance minimally invasive techniques, resulting in a trend within healthcare institutions to prioritize products that boost procedural efficiency and improve patient outcomes. This clinical inclination, coupled with broader acceptance across various surgical specialties, is driving more frequent inclusion of flowable hemostats in hospital formularies, thus promoting organic market growth.

Restraints in the Global Flowable Hemostats Market

The Global Flowable Hemostats market faces significant challenges due to complex and diverse regulatory requirements that vary by region. These regulations can hinder timely product launches and limit market penetration, especially for flowable hemostats featuring innovative biologic components or proprietary delivery mechanisms. Manufacturers are often required to navigate lengthy review processes and provide extensive data on safety and efficacy, which complicates development efforts and reallocates resources away from commercialization initiatives. Such challenges can deter smaller companies from entering the market and slow down investment in new product formulations, ultimately affecting the speed at which cutting-edge hemostatic solutions become available for clinical use.

Market Trends of the Global Flowable Hemostats Market

The Global Flowable Hemostats market is experiencing significant growth due to the escalating adoption of minimally invasive surgical techniques and robotic procedures. This trend is fueled by a clinician preference for hemostatic solutions that can effectively conform to intricate anatomies and deliver rapid hemostasis in limited spaces, thereby enhancing surgical efficacy. Hospitals are increasingly prioritizing products that contribute to shorter patient stays and optimized throughput. In response, manufacturers are innovating with improved packaging, applicator compatibility, and comprehensive training support to streamline integration into surgical workflows, creating distinct advantages that cater to the evolving demands of modern surgical practices.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Flowable Hemostats Market Size by Type of Hemostat & CAGR (2026-2033)

• Market Overview
• Fibrin-based Hemostats
• Collagen-based Hemostats
• Gelatin-based Hemostats

Global Flowable Hemostats Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Trauma Cases
• Cardiovascular Surgery
• Orthopedic Surgery
• Others

Global Flowable Hemostats Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Liquid Formulations
• Powder Formulations

Global Flowable Hemostats Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Flowable Hemostats Market Size & CAGR (2026-2033)

• North America (Type of Hemostat, Application Area, Formulation Type, End User)
  • US
  • Canada
• Europe (Type of Hemostat, Application Area, Formulation Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Hemostat, Application Area, Formulation Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Hemostat, Application Area, Formulation Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Hemostat, Application Area, Formulation Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z-Medica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILS Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemostasis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Source BioScience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acelity L.P. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations